Fairvalue-Calculator Fairvalue-Calculator
EN DE

EKF Diagnostics Holdings (EKDHF) Fair Value & Analysis

Healthcare · US · Market cap $149M

Price$0.3469
Fair Value$0.3100
Upside-10.6%
Quality93/100
Evidence: High Range $0.2300 – $0.3900

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

EKF Diagnostics Holdings (EKDHF) currently trades at $0.3469, while our model-based Fair Value estimate is $0.3100 — implying the stock looks roughly 10.6% overvalued today. We read business quality at 93/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. It also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic; Quo-Lab HbA1c, a desktop point-of-care analyzer for measuring glycated hemoglobin; Quo-Test HbA1c, fully automated hemoglobin A1c analyzer for the monitoring and management of diabetes; and STAT-Site W Beta-Hydroxybutyrate analyzer. In addition, the company offers Creamatocrit Plus, a breast milk analyzer; QuPID and True20 pregnancy tests; Lactate Scout Vet, a handheld lactate analyzer for veterinary care; Hemo Vet, a point-of-care hemoglobin and hematocrit analyzer; Lacta…

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -23% Stryker Corporation (S1YK34) -89% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -81% Edwards Lifesciences Corporation (EW) -53% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is EKF Diagnostics Holdings (EKDHF) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $0.3100 versus a price of $0.3469 — about −11% (overvalued). Model-based estimate, not financial advice.
What is the fair value of EKDHF?
Our 21-model fair value for EKF Diagnostics Holdings is $0.3100 (as of Jun 24, 2026), built from audited fundamentals. The current price is $0.3469.
What is the quality score of EKDHF?
EKF Diagnostics Holdings has a Quality Score of 93/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.